Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPI 287 with Irinotecan and Temozolomide in Neuroblastoma
NCT01505608Phase 2Terminated
- Start
- Dec 2011
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abeotaxane in neuroblastoma. Started Dec 2011; status: terminated.
02
Drugs
abeotaxane
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT01505608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01505608.